Regards student use of a nasal epinephrine delivery device

Added eligibility for chartered and nonchartered nonpublic schools, community schools, STEM schools, college-preparatory boarding schools, and camps to procure and use epinephrine delivery systems.

Expanded the definition of 'epinephrine delivery system' to explicitly include intranasal sprays and any other FDA-approved device designated by the state board of pharmacy, not just autoinjectors.

Added a requirement for the Department of Education and Workforce to compile and distribute a list of organizations offering free or reduced-cost epinephrine devices to qualifying schools and camps.

Modified prescribing rules to allow licensed nurses and other health professionals to furnish or prescribe these devices without first examining the individual.

Added new liability immunity provisions specifically for nonpublic schools, community schools, STEM schools, boarding schools, and camps regarding the use or prohibition of these devices.

Added exemptions from terminal distributor licensure requirements for the newly included school types and camps when possessing epinephrine delivery systems.

Added a new Section 2 that repeals the existing versions of the relevant code sections, ensuring the new text becomes the official law.

Reformatted the detailed list of required information on the prescriber's approval form to use a standard alphabetical list (a through l) for clarity.

Added specific immunity clauses for chartered nonpublic schools and community schools, protecting their staff from liability when managing student use of epinephrine devices.